BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3501347)

  • 21. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of tissue-type plasminogen activator-inhibitor complexes from human plasma. Evidence for a rapid plasminogen activator inhibitor.
    Thorsen S; Philips M
    Biochim Biophys Acta; 1984 Nov; 802(1):111-8. PubMed ID: 6435684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma.
    Lecander I; Astedt B
    Br J Haematol; 1986 Feb; 62(2):221-8. PubMed ID: 3484964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Quantification of a specific inhibitor (PAI-1) of tissue-type plasminogen activator (t-PA) in the plasma].
    Masson C; Angles-Cano E
    Ann Biol Clin (Paris); 1989; 47(5):269-74. PubMed ID: 2500878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator and plasminogen activator inhibitor activities in a reference population.
    Krishnamurti C; Tang DB; Barr CF; Alving BM
    Am J Clin Pathol; 1988 Jun; 89(6):747-52. PubMed ID: 3259399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor.
    Schleef RR; Higgins DL; Pillemer E; Levitt LJ
    J Clin Invest; 1989 May; 83(5):1747-52. PubMed ID: 2496147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
    Aillaud MF; Pignol F; Alessi MC; Harle JR; Escande M; Mongin M; Juhan-Vague I
    Thromb Haemost; 1986 Jun; 55(3):330-2. PubMed ID: 3092390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid inactivation of the plasminogen-activator inhibitor upon secretion from cultured human endothelial cells.
    Kooistra T; Sprengers ED; van Hinsbergh VW
    Biochem J; 1986 Nov; 239(3):497-503. PubMed ID: 3103601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased plasminogen activator inhibition levels in malignancy.
    de Jong E; Knot EA; Piket D; Iburg AH; Rijken DC; Veenhof KH; Dooijewaard G; ten Cate JW
    Thromb Haemost; 1987 Apr; 57(2):140-3. PubMed ID: 3110994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.
    Philips M; Juul AG; Thorsen S
    Biochim Biophys Acta; 1984 Nov; 802(1):99-110. PubMed ID: 6435688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasminogen activators t-PA, u-PA and its inhibitor (PAI) in normal males and females.
    Koh SC; Yuen R; Viegas OA; Chua SE; Ng BL; Sen DK; Ratnam SS
    Thromb Haemost; 1991 Nov; 66(5):581-5. PubMed ID: 1803623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for a rapid inhibitor to tissue plasminogen activator in plasma.
    Chmielewska J; Rånby M; Wiman B
    Thromb Res; 1983 Aug; 31(3):427-36. PubMed ID: 20217999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dexamethasone inhibition of tissue-type plasminogen activator (tPA) activity: paradoxical induction of both tPA antigen and plasminogen activator inhibitor.
    Gelehrter TD; Sznycer-Laszuk R; Zeheb R; Cwikel BJ
    Mol Endocrinol; 1987 Jan; 1(1):97-101. PubMed ID: 3137452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
    Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B
    J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-activator inhibitors of plasminogen].
    Juhan-Vague I; Alessi MC; Aillaud MF
    Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C
    Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasminogen activator and plasminogen activator inhibitor in human preovulatory follicular fluid.
    Jones PB; Vernon MW; Muse KN; Curry TE
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1039-45. PubMed ID: 2470770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.